<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cell cycle phases of bone marrow cells from 8 patients with <z:hpo ids='HP_0001891'>iron deficiency anemia</z:hpo> (IDA), 8 <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (AA), 30 <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), 41 <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> (AL) before treatment, 8 <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> in relapse, 17 <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> in complete remission (CR), 12 <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>) and 4 <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (CLL) were analysed with flow cytometry </plain></SENT>
<SENT sid="1" pm="."><plain>The proportions of phases of S </plain></SENT>
<SENT sid="2" pm="."><plain>G2 M in patients with IDA, <z:hpo ids='HP_0005505'>refractory anemia</z:hpo>, and <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with ring sideroblast were similar to these in <z:mpath ids='MPATH_458'>normal</z:mpath> controls (P &gt; 0.05) </plain></SENT>
<SENT sid="3" pm="."><plain>However, they were significantly lower in patients with AA, <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blast (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>) and transformed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> than those in <z:mpath ids='MPATH_458'>normal</z:mpath> controls (P &lt; 0.01, respectively), and <z:mp ids='MP_0005481'>CML</z:mp> patients than in <z:mpath ids='MPATH_458'>normal</z:mpath> controls (P &lt; 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>The S G2M% was apparently higher in patients with <z:mp ids='MP_0005481'>CML</z:mp> than that in CLL (P &lt; 0.01) </plain></SENT>
<SENT sid="5" pm="."><plain>But, there was no difference between in ALL and ANLL (P &gt; 0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>It was higher in patients with AL in CR and in relapse than AL before treatment (both P &lt; 0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>It was still lower in the former than that in <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="8" pm="."><plain>(P &lt; 0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>The clinical significance of cell cycle status was also discussed in this paper </plain></SENT>
</text></document>